| Product Code: ETC11555589 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Central Nervodisorders Therapeutics Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Central Nervodisorders Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 China Central Nervodisorders Therapeutics Market - Industry Life Cycle |
3.4 China Central Nervodisorders Therapeutics Market - Porter's Five Forces |
3.5 China Central Nervodisorders Therapeutics Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 China Central Nervodisorders Therapeutics Market Revenues & Volume Share, By Technology Type, 2021 & 2031F |
3.7 China Central Nervodisorders Therapeutics Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 China Central Nervodisorders Therapeutics Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 China Central Nervodisorders Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of central nervous system disorders in China |
4.2.2 Growing awareness and diagnosis of neurological diseases |
4.2.3 Technological advancements in therapeutic approaches for central nervous system disorders |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval in China |
4.3.2 High cost associated with central nervous system disorder therapies |
4.3.3 Limited availability of specialized healthcare professionals in the field of neurology |
5 China Central Nervodisorders Therapeutics Market Trends |
6 China Central Nervodisorders Therapeutics Market, By Types |
6.1 China Central Nervodisorders Therapeutics Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 China Central Nervodisorders Therapeutics Market Revenues & Volume, By Product Type, 2021 - 2031F |
6.1.3 China Central Nervodisorders Therapeutics Market Revenues & Volume, By Neuroprotective Drugs, 2021 - 2031F |
6.1.4 China Central Nervodisorders Therapeutics Market Revenues & Volume, By Gene Therapy, 2021 - 2031F |
6.1.5 China Central Nervodisorders Therapeutics Market Revenues & Volume, By Stem Cell Therapy, 2021 - 2031F |
6.1.6 China Central Nervodisorders Therapeutics Market Revenues & Volume, By Targeted Drug Delivery, 2021 - 2031F |
6.2 China Central Nervodisorders Therapeutics Market, By Technology Type |
6.2.1 Overview and Analysis |
6.2.2 China Central Nervodisorders Therapeutics Market Revenues & Volume, By Small Molecule Therapy, 2021 - 2031F |
6.2.3 China Central Nervodisorders Therapeutics Market Revenues & Volume, By CRISPR Technology, 2021 - 2031F |
6.2.4 China Central Nervodisorders Therapeutics Market Revenues & Volume, By Regenerative Medicine, 2021 - 2031F |
6.2.5 China Central Nervodisorders Therapeutics Market Revenues & Volume, By Nanotechnology, 2021 - 2031F |
6.3 China Central Nervodisorders Therapeutics Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 China Central Nervodisorders Therapeutics Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 China Central Nervodisorders Therapeutics Market Revenues & Volume, By Research Institutions, 2021 - 2031F |
6.3.4 China Central Nervodisorders Therapeutics Market Revenues & Volume, By Biotechnology Firms, 2021 - 2031F |
6.3.5 China Central Nervodisorders Therapeutics Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.4 China Central Nervodisorders Therapeutics Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 China Central Nervodisorders Therapeutics Market Revenues & Volume, By Treatment of Neurodegenerative Disorders, 2021 - 2031F |
6.4.3 China Central Nervodisorders Therapeutics Market Revenues & Volume, By Genetic Disorder Correction, 2021 - 2031F |
6.4.4 China Central Nervodisorders Therapeutics Market Revenues & Volume, By Neuron Regeneration, 2021 - 2031F |
6.4.5 China Central Nervodisorders Therapeutics Market Revenues & Volume, By Precision Medicine, 2021 - 2031F |
7 China Central Nervodisorders Therapeutics Market Import-Export Trade Statistics |
7.1 China Central Nervodisorders Therapeutics Market Export to Major Countries |
7.2 China Central Nervodisorders Therapeutics Market Imports from Major Countries |
8 China Central Nervodisorders Therapeutics Market Key Performance Indicators |
8.1 Number of clinical trials conducted for central nervous system disorder therapeutics in China |
8.2 Adoption rate of innovative treatment modalities for neurological diseases |
8.3 Research and development investments in neurology-focused pharmaceutical companies |
9 China Central Nervodisorders Therapeutics Market - Opportunity Assessment |
9.1 China Central Nervodisorders Therapeutics Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 China Central Nervodisorders Therapeutics Market Opportunity Assessment, By Technology Type, 2021 & 2031F |
9.3 China Central Nervodisorders Therapeutics Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 China Central Nervodisorders Therapeutics Market Opportunity Assessment, By Application, 2021 & 2031F |
10 China Central Nervodisorders Therapeutics Market - Competitive Landscape |
10.1 China Central Nervodisorders Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 China Central Nervodisorders Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here